Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HDACs/mTOR Inhibitor 1 is a dual HDACs and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies (IC50s: 0.19 nM, 1.8 nM, 1.2 nM, and >500 nM for HDAC1, HDAC6, mTOR and PI3Kα).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約6-8 週間 | ¥ 102,500 |
25 mg | 約6-8 週間 | ¥ 328,500 |
50 mg | 約6-8 週間 | ¥ 427,000 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | HDACs/mTOR Inhibitor 1 is a dual HDACs and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies (IC50s: 0.19 nM, 1.8 nM, 1.2 nM, and >500 nM for HDAC1, HDAC6, mTOR and PI3Kα). |
ターゲット&IC50 | mTOR:1.2 nM, HDAC6:1.8 nM, HDAC1:0.19 nM |
分子量 | 566.65 |
分子式 | C28H38N8O5 |
CAS No. | 2271413-06-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32.5 mg/mL (57.35 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HDACs/mTOR Inhibitor 1 2271413-06-8 Chromatin/Epigenetic DNA Damage/DNA Repair HDAC Inhibitor inhibitor inhibit